Dispute over Covid vaccines casts doubt on Clover Bio recovery
The Chinese biopharma firm faces a potentially damaging fight over a $224 million upfront payment it received in an ill-fated deal to supply Covid vaccines Key Takeaways: The Gavi international…
KE results show green shoots of recovery after real-estate winter
China’s top property broker insulated itself against a market downturn by expanding into home furnishings and rentals, helping it deliver a quarterly profit Key Takeaways: KE Holdings recorded a modest…
FAST NEWS: Ascletis Pharma’s Monkeypox Drug Gets IND Approval
The latest: Ascletis Pharma Inc. (1672.HK) announced on Thursday that the China National Medical Products Administration (NMPA) has approved an Investigational New Drug (IND) application for its oral viral polymerase…
Riding Covid Vaccine Highs, CanSino Plans Swiss Listing
The first vaccine stock to be listed in the both Mainland China and Hong Kong will issue global depositary receipts (GDRs) in SwitzerlandKey Takeaways:After successful listings in Shanghai and Hong…
FAST NEWS: Topsports’ Quarterly Sales Decline, But Shares Still Jump
The latest: Topsports International Holdings Ltd. (6110.HK), a major distributor for Nike and Adidas in China, said on Wednesday combined sales for its retail and wholesale operations registered a high-teens decline year-on-year in…
FAST NEWS: Ascletis Covid, Monkeypox Virus Inhibitor Gets U.S. Patent
The latest: Ascletis Pharma Inc. (1672.HK) said on Monday the U.S. Patent and Trademark Office (USPTO) has granted it a patent for its oral viral polymerase inhibitor ASC10 and its…
FAST NEWS: SSY Group Signs Preliminary Deal to Make Fever Medication
The latest: SSY Group Ltd. (2005.HK) said on Sunday it signed a letter of intent with a well-known Chinese pharmaceutical company to produce 1 billion to 2.5 billion ibuprofen sustained-release…
Recent Articles
RELATED ARTICLES
-
Shanghai Able’s renewed IPO plan hobbled by weak appetite for new tech listings
-
Airdoc Tech enjoys healing properties of medical AI rally
2251.HK
-
Yan Palace flies back to profit growth as revenue sags
1497.HK
- Shanghai family feud ties up $1 billion in property, offers lesson for investors
-
Despite slumping revenue, Shanghai Refire cruises on government support
2570.HK
-
NEWS WRAP: Profit plunges at JinkoSolar’s main China-listed unit
JKS.US 688223.SHG
